$6 million Alzheimer grant announced

Jun 04, 2007

The U.S. National Institutes of Health has awarded a $6 million grant for the continuation of a promising study into Alzheimer's disease treatments.

The grant was awarded University of Missouri-Columbia biochemistry Professors Grace Sun and Gary Weisman, who are entering the second phase of a project aimed at identifying the causes of Alzheimer's disease.

As many as 20 million people worldwide are affected by Alzheimer's disease, with those numbers likely to triple by 2050 as the population ages.

"In the past five years, we have started to understand how this disease works," Sun said. "With the new grant, we will be able to go forward and see if there are treatments that can modify the cellular response in the brain."

Findings from the research program have been published in the Journal of Neuroinflammation, the Journal of Neuroscience and the Journal of Biological Chemistry.

Copyright 2007 by United Press International

Explore further: Number of people susceptible to painful mosquito-borne virus increasing, says leading researcher

add to favorites email to friend print save as pdf

Related Stories

How Kindle Unlimited compares with Scribd, Oyster

2 hours ago

Amazon is the latest—and largest—company to offer unlimited e-books for a monthly fee. Here's how Kindle Unlimited, which Amazon announced Friday, compares with rivals Scribd and Oyster.

NASA sees powerful thunderstorms in Tropical Storm Matmo

2 hours ago

Strong thunderstorms reaching toward the top of the troposphere circled Tropical Storm Matmo's center and appeared in a band of thunderstorms on the storm's southwestern quadrant. Infrared imagery from NASA's ...

ISS 'space truck' launch postponed: Arianespace

4 hours ago

The July 24 launch of a robot ship to deliver provisions to the International Space Station has been postponed "for a few days", space transport firm Arianespace said Friday.

Recommended for you

Experts call for stepped-up hepatitis battle

4 hours ago

The world can beat the cancer-causing disease hepatitis if it raises its game, but treatment programmes need to go hand in hand with those tackling the likes of HIV, experts said Thursday.

User comments : 0